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Background
Timely diagnosis of hereditary angioedema (HAE) is
challenging in children. The barriers include lack of
awareness of HAE, communication difficulties, diagnos-
tic testing limitations, and broad differential diagnoses
for symptoms of HAE. Consequently, there has been no
definitive study on the age of onset of symptoms of
HAE in children. This lack of awareness can result in
reduced quality of life due to suboptimal treatment of
symptoms, significant delay in diagnosis, and/or mis-
diagnosis, which can result in unnecessary tests, treat-
ments, and procedures. Current literature suggests that
the mean age of onset is in the second decade of life,
which is worsened by puberty, estrogen containing con-
traception, or estrogen hormone replacement therapy,
but symptoms can also be present under one year. Here
we present a case report of an infant not previously
diagnosed with clinical symptoms of HAE but born
from a mother with type I HAE.
Method
Cord blood for C1-INH and C4 protein quantities were
obtained at time of delivery. Parents were requested to
monitor the child for symptoms and pictures were taken to
document any clinically suspicious edema and/or rashes.
Repeat laboratory testing was done after 1 year of age.
Results
Cord blood results show C1-INH <0.12 (0.21-0.39) g/L and
C4 0.08 (0.07 – 0.30) g/L. At 9 months, the child’s mother
noted slight periorbital edema, which was documented
with pictures. At 14 and 18 months, the child developed a
rash on her torso and arms that resembled erythema mar-
ginatum; both episodes were documented with pictures.
Conclusion
Clinical symptoms of HAE may begin as early as 9 months
without any triggers. Parents and clinicians need to be vig-
ilant and properly diagnose HAE to optimize the quality
of life for these young patients and their families. We
emphasize a high index of clinical suspicion of HAE
should begin even in the early infant period.
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